Get started
Work

MPN-973: A Phase 3, Double-Blind, Randomized Trial Evaluating the Efficacy and Safety of Elritercept vs Placebo in Patients With Myelofibrosis and Anemia on Concurrent Ruxolitinib Therapy: The ELRISE MF Study Design

Year: 2026
Type: conference-abstract
DOI: 10.1016/s2152-2650(26)02375-x
Authors: Prithviraj Bose, Haifa Kathrin Al-Ali, Lina Benajiba, Francesco Passamonti, Francesca Palandri, María Laura Fox, Andrew T Kuykendall, John O Mascarenhas, Aaron T Gerds, David M Ross, Katsuto Takenaka, Katsuhiro Togami, Leopold Sellner, Amy Sexauer, Rizvan Bush, Claire Harrison
Institutions: The University of Texas MD Anderson Cancer Center, University Hospital in Halle, Inserm, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Louis, Centre d'Investigation Clinique Saint-Louis, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Istituto di Ematologia di Bologna, University of Bologna, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, Moffitt Cancer Center, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Cleveland Clinic, Flinders University, Ehime University, Guy's and St Thomas' NHS Foundation Trust
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W7204682173
Cites:
Cited by:
Related to: 10